"Ozempic face" is the facial volume loss, hollowing, and skin laxity that can follow rapid weight loss on GLP-1 medications. Red light therapy cannot restore lost fat volume, but it is studied for supporting skin firmness and collagen, which may help skin adapt more gracefully during major body change. It is a supportive tool for skin resilience, not a fix for volume loss. The fundamentals (a sensible rate of loss, adequate protein, and a dermatologist's input) matter more.

Red light therapy has solid evidence for reducing delayed onset muscle soreness (DOMS) and markers of muscle damage, and emerging evidence for improving performance when used before training. Meta-analyses show it lowers soreness and creatine kinase levels, with the most consistent results when light is applied before exercise. It works by supporting the way muscle cells produce energy. It is a legitimate recovery tool, not a shortcut, and works best layered onto solid training, sleep, and nutrition.

Red light therapy and mitochondrial support supplements like CoQ10 and PQQ target the same organelle through different mechanisms. Red light stimulates ATP production in existing mitochondria via cytochrome c oxidase. CoQ10 fuels the electron transport chain that generates ATP. PQQ and urolithin A support mitochondrial renewal and cleanup. Because they work through complementary pathways, some longevity-focused users combine them, though the human evidence for the combination specifically is still emerging.

Wall-mounted red light therapy panels deliver more raw power and treat larger areas in a single session, but require dedicated space and stay in one room. Portable panels offer lower total coverage but win on consistency because they travel, work in apartments, and integrate into rooms you actually use. For most home users, a portable panel between 100 and 200 mW/cm² is enough for targeted recovery if used 4 to 5 times per week.

Red light therapy has reasonable evidence for reducing joint stiffness and pain, particularly in knee osteoarthritis. A 2024 network meta-analysis of 13 randomized controlled trials involving 673 patients found that low-level light therapy was significantly superior to sham treatment for reducing knee OA pain. Effects typically appear at 2 to 6 weeks of consistent use, 3 to 5 sessions per week, using near-infrared wavelengths at 850nm or above.